BLACK FRIDAY SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim→
logo

SUVEN vs VIMTALABS: Stock Comparison

SUVEN LIFE SCIENCES vs VIMTA LABSUpdated 20 Nov 26, 4:08 PM ISTNSE & company filings

SUVEN LIFE SCIENCES is the larger company by market capitalisation. SUVEN LIFE SCIENCES shows lower leverage, while VIMTA LABS shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SUVEN leads 2; VIMTALABS leads 10 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SUVENVIMTALABS

Valuation lens

What price are you paying?

Market CapContext only
₹7,609 Cr
₹2,083 Cr
P/E RatioSame reading
0x
0x
P/B RatioVIMTALABS has the lower reading
15.66x
0x ✓
EPSVIMTALABS has the higher reading
₹-3.78
₹4.84 ✓
Book ValueContext only
₹20.93
₹102.84
Dividend YieldVIMTALABS has the higher reading
0%
0.43% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SUVEN is the larger company
₹7,609 Cr vs ₹2,083 Cr
P/B Ratio
VIMTALABS has a lower P/B
0x vs 15.66x
EPS
VIMTALABS has higher earnings per share
₹4.84 vs ₹-3.78
Dividend Yield
VIMTALABS has a higher dividend yield
0.43% vs 0%
Revenue Growth (TTM YoY)
VIMTALABS has faster revenue growth
16.5% vs 3.6%
EPS Growth (TTM YoY)
VIMTALABS has faster EPS growth
14.3% vs 0%
Qtr Sales Growth
VIMTALABS has stronger quarterly sales growth
0% vs -66.39%
Qtr Profit Growth
SUVEN has stronger quarterly profit growth
16.2% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSUVENVIMTALABS
SectorHealthcareHealthcare
IndustryHealthcare Research Analytics & TechnologyHealthcare Research Analytics & Technology

Price

MetricSUVENVIMTALABS
Live Price₹269.4₹467.65
Day Change-2.71%-0.91%
Volume3.34 L49,984
52-Week High₹403.35₹675
52-Week Low₹124.11₹376.05
Distance from 52W High-33.21%-30.72%

Valuation

MetricSUVENVIMTALABS
Market Cap₹7,609 Cr₹2,083 Cr
P/E Ratio0x0x
P/B Ratio15.66x0x
EPS₹-3.78₹4.84
Book Value₹20.93₹102.84
Dividend Yield0%0.43%

Growth

MetricSUVENVIMTALABS
Revenue Growth (TTM YoY)3.6%16.5%
EPS Growth (TTM YoY)0%14.3%
Qtr Sales Growth-66.39%0%
Qtr Profit Growth16.2%0%

Profitability & Leverage

MetricSUVENVIMTALABS
ROE-3.65%16.97%
ROCE-3.64%17.48%
Net Margin-3,884.13%19.03%
Operating Margin-768.9%25.81%
Debt to Equity0x0.01x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricSUVENVIMTALABS
Promoter Holding65.47%35.64%▼ 0.03 pp
FII Holding0.46%▼ 0.02 pp5.07%▲ 0.65 pp
DII Holding2.17%▼ 0.56 pp0.48%▲ 0.11 pp
Public Holding31.9%▲ 0.58 pp58.8%▼ 0.75 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SUVEN LIFE SCIENCES and VIMTA LABS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.